Since 2024: Glaring Reality Keeps AbbVie on Hold
AbbVie’s stock has climbed since 2024, yet a stubborn balance sheet and looming biosimilar erosion create a cautious ...
Explore effective ways to get paid this week and take control of your financial situation quickly.
13,137 articlesAbbVie’s stock has climbed since 2024, yet a stubborn balance sheet and looming biosimilar erosion create a cautious ...
SpaceX is set to go public on NASDAQ this Friday, with analysts predicting a historic IPO. Markets monitor the offeri...
Walmart pledges to upskill its 2.1 million workers with AI tools, saying technology will enhance work rather than wip...
AI growth is outpacing grid upgrades. This article explains why electricity is the bottleneck and how three stocks—Bl...
A federal judge invalidated the White House’s $100,000 H-1B filing fee, creating immediate uncertainty for U.S. emplo...
Bitcoin rose past $65,000 on Monday as reports of a potential U.S.-Iran peace agreement eased geopolitical fears. Ana...
A sweeping budget package introduced in Congress is fuelling new concerns over Social Security and Medicare solvency,...
As the chip index climbs, fund managers sit on a cautious chair, weighing gains against risk. Bank of America flags p...
Robinhood unveils a fresh round of layoffs, cutting about 290 jobs to streamline its structure, while reporting solid...
Traders are coalescing around MANGOS stocks as AI-driven catalysts lift a new set of winners. The shift hints at a br...
Perplexity's CEO champions a no-fear mindset to seize opportunities as AI disruption reshapes the job market. He repe...
SpaceX’s public-market debut fueled an ascent in Elon Musk’s net worth to about $1.32 trillion, surpassing Bitcoin’s ...